These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39192568)

  • 1. AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer.
    Xie H; Wei L; Ruan G; Zhang H; Shi J; Lin S; Liu C; Liu X; Zheng X; Chen Y; Chen J; Shi H
    J Cachexia Sarcopenia Muscle; 2024 Oct; 15(5):2084-2093. PubMed ID: 39192568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the fat-free mass index-based cachexia index in patients with colorectal cancer.
    Qin Y; Xie H; Liu T; Zhang H; Liu C; Li X; Bu Z; Liu X; Lin S; Chen Y; Zheng X; Zhao H; Shi J; Shi H
    Sci Rep; 2024 Oct; 14(1):24390. PubMed ID: 39420045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and prognostic impact of cancer cachexia defined by the Asian Working Group for Cachexia consensus in patients with curable gastric cancer.
    Zhang FM; Zhuang CL; Dong QT; Yu Z; Cheng J; Shen X; Wang SL
    Clin Nutr; 2024 Jun; 43(6):1524-1531. PubMed ID: 38744096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the diagnostic criteria from the Asian Working Group for Cachexia in advanced cancer.
    Sakaguchi T; Maeda K; Takeuchi T; Mizuno A; Kato R; Ishida Y; Ueshima J; Shimizu A; Amano K; Mori N
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):370-379. PubMed ID: 38115133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.
    Xie H; Ruan G; Wei L; Deng L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Yang M; Song C; Zhang X; Shi H
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):869-878. PubMed ID: 36852672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the assessment of malnutrition in cancer: Using systemic inflammation markers as a supplement to the inflammation items of the GLIM criteria.
    Xie H; Yuan K; Ruan G; Wei L; Zhang H; Ge Y; Lin S; Song M; Wang Z; Liu C; Shi J; Liu X; Yang M; Zheng X; Chen Y; Zhang X; Shi H
    Clin Nutr; 2023 Oct; 42(10):2036-2044. PubMed ID: 37672850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care.
    Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W
    J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054
    [No Abstract]   [Full Text] [Related]  

  • 10. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
    Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
    BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated neutrophil-to-lymphocyte ratio and handgrip strength better predict survival in patients with cancer cachexia.
    Zhang KL; Zhou MM; Wang KH; Weng M; Zhou FX; Cui JW; Li W; Ma H; Guo ZQ; Li SY; Chen JQ; Wu XH; Zhao QC; Li JP; Xu HX; Shi HP; Song CH
    Nutrition; 2024 Jun; 122():112399. PubMed ID: 38493542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hand grip strength-based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer.
    Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Gan J; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):382-390. PubMed ID: 36447437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia.
    Xie HL; Ruan GT; Wei L; Zhang Q; Ge YZ; Song MM; Zhang X; Lin SQ; Liu XY; Zhang XW; Li XR; Zhang KP; Hu CL; Yang M; Tang M; Song CH; Cong MH; Weng M; Li ZN; Li W; Wang KH; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):879-890. PubMed ID: 36872512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triceps skinfold-albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study.
    Yin L; Cui J; Lin X; Li L; Li N; Fan Y; Zhang L; Liu J; Chong F; Lu Z; Wang C; Liang T; Liu X; Deng L; Yang M; Yu J; Wang X; Cong M; Li Z; Weng M; Yao Q; Jia P; Guo Z; Li W; Song C; Shi H; Xu H
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):517-533. PubMed ID: 36567070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA).
    Blum D; Stene GB; Solheim TS; Fayers P; Hjermstad MJ; Baracos VE; Fearon K; Strasser F; Kaasa S;
    Ann Oncol; 2014 Aug; 25(8):1635-42. PubMed ID: 24562443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis.
    Thompson JJ; McGovern J; Roxburgh CSD; Edwards J; Dolan RD; McMillan DC
    Crit Rev Oncol Hematol; 2024 Jul; 199():104378. PubMed ID: 38754770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory burden as a prognostic biomarker for cancer.
    Xie H; Ruan G; Ge Y; Zhang Q; Zhang H; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Shi H
    Clin Nutr; 2022 Jun; 41(6):1236-1243. PubMed ID: 35504166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive evaluation of serum hepatic proteins in predicting prognosis among cancer patients with cachexia: an observational cohort study.
    Huang JX; Zhang X; Tang M; Zhang Q; Deng L; Song CH; Li W; Shi HP; Cong MH
    BMC Cancer; 2024 Mar; 24(1):293. PubMed ID: 38438901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
    Xu XL; Yu HQ; Hu W; Song Q; Mao WM
    PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of fluid retention on prognostic abilities of cachexia diagnostic criteria in cancer patients with refractory cachexia.
    Amano K; Okamura S; Baracos VE; Mori N; Sakaguchi T; Uneno Y; Hiratsuka Y; Hamano J; Miura T; Ishiki H; Yokomichi N; Hatano Y; Morita T; Mori M;
    Clin Nutr ESPEN; 2024 Apr; 60():373-381. PubMed ID: 38479937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.